CD28 and neoplasm: PBMCs required addition of lipopolysaccharide (LPS) and interferon-γ (IFN-γ) or anti-CD3/anti-CD28 beads, i.e. immune cell activation, to reduce tumor spheroid size (Figure 1A,B).